US university psychiatrist loses chairmanship over drug company payments
Tanne, J.Hopkins.
Bmj 338: A3188
2009
ISSN/ISBN: 0959-8138 PMID: 19126618 Document Number: 629159
Document emailed within 1 workday
Related Documents
McCarthy, M. 2014: US intends to publish drug company payments to doctors from October despite calls for delay Bmj 349: G5693Carlson, J. 2012: Doctors of interest. Recipients of suspect drug-company payments academic medical centers, have drawing attention of federal fraud enforcers Modern Healthcare 42(34): 6-7; 16, 1
Lutz, S. 1991: HCFA loses bid to recoup home dialysis payments Modern Healthcare 21(4): 10
Calanca, A. 1978: The psychiatrist and drug addicts. Is drug addiction of any interest to the psychiatrist? Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 122(1): 125-126
Silverman, E. 2010: Drug pipeline loses pressure Managed Care 19(8): 23-26
Retterstol, N. 1974: New tranquilizing agents. Viewpoints from a psychiatrist on drug use and drug abuse Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 94(25): 1539-1542
Kobayashi, M.; Fukushmima, S.; Kawano, K.; Ohnishi, A.; Ogiwara, T.; Hagiwara, T.; Takahashi, T.; Washizuka, S.; Amano, N. 2011: Psychiatric occupational therapy practice in Shinshu University Hospital--collaboration with psychiatrist Seishin Shinkeigaku Zasshi 113(3): 301-308
Kohl, F.; von Gudden, B. 1994: Bernhard von Gudden (1824-1886)--institutional psychiatrist, brain anatomist and influential university teacher Psychiatrische Praxis 21(4): 162-166
Nowicki, P.L. 1989: Conservation and landscape ecology: evolution from compensation payments to management agreement payments Economic aspects of environmental regulations in agriculture Proceedings of the 18th Symposium of the European Association of Agricultural Economists EAAE, November 1-4, 1988, Tune, Copenhagen, Denmark: 109-115
Sargent, J.A.; Paget, M.; Clevenger, I. 1991: Planned cuts in drug payments latest in trend by HCFA seeking more for less Nephrology News and Issues 5(6): 14-16
Pfeil-Doyle, J.L.; Jones, M.D.; Oberlin, J.A.; Benitez, J. 1990: Drug information services at Eli Lilly and Company American Journal of Hospital Pharmacy 47(9): 1996-1998
Kovac, C. 2001: Drug company breaks 30 year agreement on patient advertising Bmj 323(7311): 470
Kang, G. 2010: HPV vaccines: separating real hope from drug company hype Indian Journal of Medical Ethics 7(1): 56-57
Evans, A.E. 1976: Anaconda Company and Chile Copper Company v. Overseas Private Investment Corporation. Case No. 16 10 0071 72 American Journal of International Law 70(1): 135-138
Lazar, E.J.; Banks, D.; Graham, C.; Adams, D.; Rheinstein, P.H.; Gross, M.; Witt, A.M. 1992: Drug company sponsorship of education: the response to the FDA draft concept paper JAMA 268(1): 53-54
Taylor, M. 2004: Alleged improprieties. Trial could affect hospital-drug company relationships Modern Healthcare 34(20): 20-21
Vlcek, J.; Sleszarová, P.; Pozlerová, E.; Kotlár, J.; Bláha, V.; Mashburn, J. 2000: The antibiotic resistance survey: a preliminary report on the drug utilization evaluation study at the University Teaching Hospital, Charles University, Czech Republic Pharmacoepidemiology and drug safety 9(3): 237-243
Gale, A.H. 2016: Drug Company Compensated Physicians Role in Causing America's Deadly Opioid Epidemic: When Will We Learn? Missouri Medicine 113(4): 244-246
Gadacz, T.R. 2000: Challenges to academic surgery. Life cycles in chairmanship: the first decade Bulletin of the American College of Surgeons 85(5): 21-25
Fadahunsi, O. 1990: The State holding corporation in Nigeria : the evolution of the new Nigeria development company Ltd and ODU'a investment company Ltd Public Enterprise 10(1): 131-138